1.
S. Vincent Rajkumar. The high cost of prescription drugs: causes and solutions. Blood Cancer Journal. 2020;10(6):71. doi:10.1038/s41408-020-0338-x
Costs and Cost Analysis
1.
Joseph A. DiMasi, Henry G. Grabowski, Ronald W. Hansen. Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics. 2016;47:20-33. doi:10.1016/j.jhealeco.2016.01.012
1.
Simon Wessely. Peer review of grant applications: what do we know?. The Lancet. 1998;352(9124):301-305. doi:10.1016/S0140-6736(97)11129-1